Keynote Speaker

Dr. Hanley is the Chief and Director of the Cellular Therapy Program and an associate professor of
pediatrics at Children’s National Hospital and George Washington University, respectively. He oversees
processing for standard of care stem cell transplantation as well as the development, manufacture,
quality, and testing of novel cell and gene therapies. Over the past 20 years he has helped to translate
more than 600 products on over 25 cell therapy protocols into the clinic, including mesenchymal stromal
cells, virus-specific T cells, tumor-associated antigen-specific T cells, and CAR T cells.
In 2020 Dr. Hanley was elected VP-North America of the International Society for Cell and Gene Therapy
(ISCT) where he also served on the board of directors, co-founded and served as the inaugural co-chair
of the Early Stage Professionals committee which focuses on workforce development, and is the
commissioning editor of the society’s journal, Cytotherapy. Representing ISCT, he serves on the
Regenerative Medicine Forum of the National Academies where he co-leads the workforce working
group. He also serves on the board of directors of the Foundation for the Accreditation of Cellular
Therapy (FACT) and is a FACT representative at the Cell Therapy Liaison Meeting, serving as a thought
leader in a forum with the FDA. Dr Hanley also serves as an advisor for a number of cell and gene
therapy biotech companies.
In an attempt to connect the mid-Atlantic cell and gene therapy community, in 2023 Dr Hanley formed the
CHARM network which is a regional network that provides quarterly meet ups, regular webinars, and an
annual symposium featuring local universities, government, healthcare systems, patient advocacy
groups, and biotech. In his free time, he enjoys tweeting with fellow scientists and Bills fans, playing
soccer, cycling, cooking, and traveling.